Researchers determine how the SARS-CoV-2 virus hijacks and rapidly causes damage to human lung cells: Identify clinically approved medications that can be re-purposed for COVID-19 treatment 

Researchers have identified host proteins and pathways in lung cells whose levels change upon infection by the SARS-CoV-2, providing insights into disease pathology and new therapeutic targets to block COVID-19.

Source: Researchers determine how the SARS-CoV-2 virus hijacks and rapidly causes damage to human lung cells: Identify clinically approved medications that can be re-purposed for COVID-19 treatment — ScienceDaily